Form 8-K - Current report:
SEC Accession No. 0001493152-24-044425
Filing Date
2024-11-12
Accepted
2024-11-12 06:02:21
Documents
15
Period of Report
2024-11-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38923
2 ex16-1.htm EX-16.1 8291
3 ex16-1_001.jpg GRAPHIC 5032
  Complete submission text file 0001493152-24-044425.txt   226114

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE anav-20241031.xsd EX-101.SCH 3006
5 XBRL LABEL FILE anav-20241031_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE anav-20241031_pre.xml EX-101.PRE 24159
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3367
Mailing Address 11801 PIERCE ST., 2ND FLOOR RIVERSIDE CA 92505
Business Address 11801 PIERCE ST., 2ND FLOOR RIVERSIDE CA 92505 951-530-1862
ALPHA NETWORK ALLIANCE VENTURES INC. (Filer) CIK: 0001491829 (see all company filings)

EIN.: 451649826 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54126 | Film No.: 241442712
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)